Showing results (21-30 of 72) with videos related to

Sort By:
Pageof 8
International Journal of Molecular Sciences|February 11, 2023
Androgen Deprivation Freezes Hormone-Sensitive Prostate Cancer Cells in a Reversible, Genetically Unstable Quasi-Apoptotic State, Bursting into Full Apoptosis upon Poly(ADP-ribose) Polymerase InhibitionAndrea Pelliccia, Francesco Capradossi, Francesca Corsi, et al.
Frontiers in Pharmacology|June 21, 2021
Continuous Complete Remission in Two Patients with Acute Lymphoblastic Leukemia and Severe Fungal Infection Following Short-Term, Dose-Reduced ChemotherapyFlorian Lüke, Dennis C Harrer, Joachim Hahn, et al.
Frontiers in Oncology|July 11, 2022
Drug Repurposing by Tumor Tissue EditingFlorian Lüke, Dennis Christoph Harrer, Pan Pantziarka, et al.
Cancer|October 8, 2004
Pioglitazone and rofecoxib combined with angiostatically scheduled trofosfamide in the treatment of far-advanced melanoma and soft tissue sarcomaAlbrecht Reichle, Klaus Bross, Thomas Vogt, et al.
International Journal of Molecular Sciences|February 15, 2022
Apoptosis as Driver of Therapy-Induced Cancer Repopulation and Acquired Cell-Resistance (CRAC): A Simple In Vitro Model of Phoenix Rising in Prostate CancerFrancesca Corsi, Francesco Capradossi, Andrea Pelliccia, et al.
Frontiers in Pharmacology|December 14, 2018
Biomodulatory Treatment With Azacitidine, All-trans Retinoic Acid and Pioglitazone Induces Differentiation of Primary AML Blasts Into Neutrophil Like Cells Capable of ROS Production and PhagocytosisSebastian Klobuch, Tim Steinberg, Emanuele Bruni, et al.
International Journal of Molecular Sciences|November 15, 2018
Peroxisome Proliferator-Activated Receptors (PPAR)γ Agonists as Master Modulators of Tumor TissueDaniel Heudobler, Michael Rechenmacher, Florian Lüke, et al.
BMC Research Notes|January 7, 2011
Renal function during rofecoxib therapy in patients with metastatic cancer: retrospective analysis of a prospective phase II trialStephan W Reinhold, Albrecht Reichle, Sonja Leiminger, et al.
Frontiers in Chemistry|February 18, 2022
A Proteomic Platform Enables to Test for AML Normalization In VitroSamuel M Meier-Menches, Benjamin Neuditschko, Lukas Janker, et al.
Biomarker Insights|August 20, 2009
C-reactive Protein in Patients with Metastatic Clear Cell Renal Carcinoma: An Important Biomarker for Tumor-associated InflammationAlbrecht Reichle, Jochen Grassinger, Klaus Bross, et al.
Pageof 8